This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
Today, one small pill holds the potential to transform cognitive medicine by addressing conditions like depression and Alzheimer’s.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
MZ2 | Ann: Class A2 Monthly Interest Payment | 26/03/19 | 0 | 34 | |||
|
|||||||
MZ2 | Ann: Class A1 Monthly Interest Payment | 26/03/19 | 0 | 33 | |||
|
|||||||
MZ2 | Ann: Appointment of Director | 18/03/19 | 0 | 60 | |||
|
|||||||
MZ2 | Ann: Class A2 Monthly Interest Payment | 26/02/19 | 0 | 79 | |||
|
|||||||
MZ2 | Ann: Class A1 Monthly Interest Payment | 26/02/19 | 0 | 75 | |||
|
|||||||
MZ2 | Ann: Class A2 Monthly Interest Payment | 24/01/19 | 0 | 73 | |||
|
|||||||
MZ2 | Ann: Class A1 Monthly Interest Payment | 24/01/19 | 0 | 72 | |||
|
|||||||
MZ2 | Ann: Class A2 Monthly Interest Payment | 27/12/18 | 0 | 162 | |||
|
See All Discussions